Jan 30, 2025, 00:00 by Sarah Shelson

Jan 29, 2025, 15:10 by Sarah Shelson

Jan 29, 2025, 11:18 by ASAM Weekly Editors

Beyond Buprenorphine in the ED: Leveraging Lessons From 10 Years of Implementation

Jan 27, 2025, 10:29 by Sarah Shelson

Jan 27, 2025, 05:00 by Kenneth Minkoff, MD

The opioid toxicity crisis remains an urgent public health priority across the US and Canada. Since the seminal randomized controlled trial published in 2015 found that buprenorphine initiation in the emergency department (ED) was superior compared with referral to treatment alone, buprenorphine initiation in the ED has been hailed as an important mechanism for addressing the overdose crisis.

Jan 27, 2025, 00:00 by Sarah Shelson

Jan 24, 2025, 17:04 by Sarah Shelson

Jan 24, 2025, 11:22 by Sarah Shelson

Jan 22, 2025, 10:08 by ASAM Weekly Editors

Current Advances in Behavioral Addictions

Jan 17, 2025, 17:23 by Sarah Shelson

Jan 16, 2025, 12:21 by Sarah Shelson

Jan 15, 2025, 12:58 by ASAM Weekly Editors

Review of Evidence on Alcohol and Health

Jan 9, 2025, 12:00 by Sarah Shelson

Jan 7, 2025, 12:06 by ASAM Weekly Editors

2024 ASAM Weekly Guest Editorials

Jan 3, 2025, 14:33 by ASAM Weekly Editors

ASAM Weekly Top 10 News Articles of 2024

Dec 26, 2024, 13:35 by ASAM Weekly Editors

ASAM Weekly Top 10 Peer-Reviewed Scientific Publications of 2024

Dec 21, 2024, 09:18 by Sarah Shelson

Dec 19, 2024, 08:22 by Sarah Shelson

Dec 16, 2024, 14:14 by Kelly Corredor

Dec 11, 2024, 10:44 by ASAM Weekly Editors

The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder